Need professional-grade analysis? Visit stockanalysis.com
$2.53B
104.81
N/A
N/A
Veracyte Inc (VCYT) trades on United States in USD. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at $32.94, up 3.45% from the previous close.
Over the past year, VCYT has traded between a low of $23.03 and a high of $49.38. The stock has gained 6.1% over this period. It is currently 33.3% below its 52-week high.
Veracyte Inc has a market capitalization of $2.53B, with a price-to-earnings ratio of 104.81.
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.